Hormonal
Real-world use of tirzepatide for obesity management without type 2 diabetes involves significantly slower dose escalation and lower adherence compared to clinical trial protocols, with most patients remaining on doses ≤10 mg and roughly half discontinuing treatment within six months.
In real-world practice, tirzepatide is often used at lower doses (≤10 mg) than in clinical trials, and about half of patients stop treatment within six months. If you are using it, expect that dose escalation may be slower than recommended, and persistence is a challenge. If you discontinue, switching to another GLP-1 agonist like semaglutide is a common next step.
Tirzepatide dose escalation in this real-world cohort was slower than in clinical trials... At the fifth prescription refill (n = 448), 91.1% were receiving tirzepatide doses of ≤10 mg... At 6 months, tirzepatide adherence was 55.5% and persistence was 54.2%.
Why this rating
Large retrospective cohort study (N=10,193) with real-world data, though observational and subject to coding limitations.
Source
Real‐world use of tirzepatide among individuals without evidence of type 2 diabetes: Results from the Veradigm® database
Theresa Hunter et al. · Diabetes Obesity and Metabolism · 2025
DOI 10.1111/dom.16330
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →